Hemolytic Anemia After Surgical Mitral Valve Repair Treated With Transcatheter Edge-to-Edge Device

Adrià Ruiz-López; Chi-Hion Pedro Li; Pilar Valdovinos; Álvaro Rodríguez; Ana Bonet; Manel Tauron; Carmen Ligero; Xavier Millan; Josep M Alegret; David Viladés; Dabit Arzamendi

doi:10.1016/j.jaccas.2022.03.021

Hemolytic Anemia After Surgical Mitral Valve Repair Treated With Transcatheter Edge-to-Edge Device

JACC Case Rep. 2022 Jun 15;4(12):727-731. doi: 10.1016/j.jaccas.2022.03.021.

Affiliations

¹ Department of Cardiology, Hospital de la Santa Creu i Sant Pau, Autonomous University of Barcelona, Barcelona, Spain.
² Department of Cardiology, Sant Joan de Reus University Hospital, University of Rovira i Virgili, Reus, Spain.
³ Department of Cardiac Surgery, Hospital de la Santa Creu i Sant Pau, Autonomous University of Barcelona, Barcelona, Spain.

Abstract

An 80-year-old woman with mitral valve repair failure was admitted with hemolytic anemia secondary to the impact of a regurgitant jet on the annuloplasty ring. Transcatheter repair to treat both mitral regurgitation and hemolysis was favored because of surgical risk. Transcatheter edge-to-edge repair represents an alternative for treating hemolysis associated with mitral regurgitation. (Level of Difficulty: Advanced.).

Keywords: MR, mitral regurgitation; MVRe, [surgical] mitral valve repair; TEER, transcatheter-edge-to-edge repair; hemolysis; mitral valve repair; mitral regurgitation; transcatheter-edge-to-edge repair.

Publication types

Case Reports